CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 93 filers reported holding CYTOSORBENTS CORP in Q4 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $53,000 | -8.6% | 24,367 | +33.3% | 0.00% | -20.0% |
| Q1 2022 | $58,000 | -27.5% | 18,275 | -4.4% | 0.01% | -28.6% |
| Q4 2021 | $80,000 | -55.8% | 19,114 | -14.3% | 0.01% | -68.2% |
| Q3 2021 | $181,000 | +19.9% | 22,312 | +11.4% | 0.02% | -4.3% |
| Q2 2021 | $151,000 | +3.4% | 20,031 | +19.2% | 0.02% | -28.1% |
| Q1 2021 | $146,000 | – | 16,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $1,616 | 1.58% |
| Skylands Capital, LLC | 2,793,470 | $10,028,557 | 1.44% |
| Sargent Investment Group, LLC | 1,289,546 | $4,629,470 | 1.12% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 237,940 | $854,205 | 0.96% |
| Avenir Corp | 2,719,732 | $9,763,838 | 0.86% |
| Granahan Investment Management | 1,616,587 | $5,803,547 | 0.18% |
| Seelaus Asset Management LLC | 20,450 | $73 | 0.06% |
| Cowen Prime Advisors LLC | 42,301 | $151,861 | 0.05% |
| HighMark Wealth Management LLC | 10,000 | $35,900 | 0.03% |
| Key Client Fiduciary Advisors, LLC | 12,000 | $43,080 | 0.02% |